FDA regulators assure Ideomed that the company's Abriiz app won't need formal regulatory review under the FDA's mobile medical device "enforcement discretion" process.
Michigan medical app maker Ideomed will get to dodge FDA review for its medical app, allowing the company to save a lot of time and money in reaching a larger audience.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1w4caHl
Cap comentari:
Publica un comentari a l'entrada